Anticoagulation et fragilité osseuse : quelles implications pour la pratique clinique ? [Anticoagulant and bone fragility: which implications for clinical practice?]

Détails

Ressource 1Télécharger: RMS_Anticoagulation et fragilité osseuse.pdf (108.28 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_A7DBE0CB1C53
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Anticoagulation et fragilité osseuse : quelles implications pour la pratique clinique ? [Anticoagulant and bone fragility: which implications for clinical practice?]
Périodique
Revue medicale suisse
Auteur⸱e⸱s
Pelet A., Lamy O.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
21/04/2021
Peer-reviewed
Oui
Volume
17
Numéro
735
Pages
766-769
Langue
français
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
The role of certain treatments in the development of bone fragility is well known. Since the 2000s, several studies, conducted in patients on long-term anticoagulants have suggested the involvement of vitamin K antagonist (VKA) in the occurrence of osteoporotic fractures. Since their launch in 2008, the new oral anticoagulants (NOACs) have been widely used. Compared to VKA, this drugs' class is associated with a lower fracture risk. Therefore, the presence of risk factors for fracture should be considered when prescribing long-term anticoagulants. In this line, the NOACs seem to be an interesting alternative for patients at risk of fracture requiring a long-term anticoagulation. Nevertheless, certain aspects remain to be clarified.
Mots-clé
Administration, Oral, Anticoagulants/adverse effects, Atrial Fibrillation/drug therapy, Humans, Osteoporotic Fractures/epidemiology, Osteoporotic Fractures/prevention & control, Risk Factors, Stroke, Vitamin K/therapeutic use
Pubmed
Création de la notice
11/05/2021 10:50
Dernière modification de la notice
30/12/2023 8:16
Données d'usage